Watson gets generic Plan B One-Step approval
This article was originally published in Scrip
Executive Summary
Watson Laboratories (a subsidiary of Watson Pharmaceuticals) has received US FDA approval for its ANDA for Next Choice One Dose (levonorgestrel tablet, 1.5mg), a generic version of Teva Women's Heath's Plan B One-Step. Watson says it will launch the product immediately.